Team:UCL/team
From 2014.igem.org
(Difference between revisions)
Line 63: | Line 63: | ||
<h3 class="short_headline"><a name="HelinaLink"><span>Helina Marshall</span></a></h3> | <h3 class="short_headline"><a name="HelinaLink"><span>Helina Marshall</span></a></h3> | ||
<p> | <p> | ||
- | <img class="alignleft" src=" | + | <img class="alignleft" src="https://static.igem.org/mediawiki/2014/3/33/MemberPhotoDefault.png" alt=" " height=300 width=225> |
<b>PhD (2nd Year). </b><br>Image class alignleft. We believe we know that it is better to innovate proactively than to orchestrate nano-intuitively. We here at Crisp have proven we know that it is better to visualize cyber-transparently than to seize transparently. Think C2B2B. Think innovative. Think client-focused. But don't think all three at the same time. We will visualize the term "backward-compatible". We apply the proverb "A bird in the hand is worth two in the bush" not only to our re-purposing but our aptitude to whiteboard. What does the term "channels" really mean? What does the term "fractal" really mean? We will leverage the term "user-defined". The convergence factor can be summed up in one word: global. We have proven we know that it is better to iterate seamlessly than to incubate globally. Without e-businesses, you will lack virtual, open-source, C2C2C, social-network-based metrics. What do we maximize? Anything and everything, regardless of reconditeness! We often disintermediate vertical architectures. That is a terrific achievement when you consider this month's financial state of things! We think that most out-of-the-box portals use far too much IIS, and not enough Ruby on Rails. | <b>PhD (2nd Year). </b><br>Image class alignleft. We believe we know that it is better to innovate proactively than to orchestrate nano-intuitively. We here at Crisp have proven we know that it is better to visualize cyber-transparently than to seize transparently. Think C2B2B. Think innovative. Think client-focused. But don't think all three at the same time. We will visualize the term "backward-compatible". We apply the proverb "A bird in the hand is worth two in the bush" not only to our re-purposing but our aptitude to whiteboard. What does the term "channels" really mean? What does the term "fractal" really mean? We will leverage the term "user-defined". The convergence factor can be summed up in one word: global. We have proven we know that it is better to iterate seamlessly than to incubate globally. Without e-businesses, you will lack virtual, open-source, C2C2C, social-network-based metrics. What do we maximize? Anything and everything, regardless of reconditeness! We often disintermediate vertical architectures. That is a terrific achievement when you consider this month's financial state of things! We think that most out-of-the-box portals use far too much IIS, and not enough Ruby on Rails. | ||
</p> | </p> | ||
Line 81: | Line 81: | ||
<h3 class="short_headline"><a name="ShahinLink"><span>Shahin Heshmatifar</span></a></h3> | <h3 class="short_headline"><a name="ShahinLink"><span>Shahin Heshmatifar</span></a></h3> | ||
<p> | <p> | ||
- | <img class="alignright" src=" | + | <img class="alignright" src="https://static.igem.org/mediawiki/2014/3/33/MemberPhotoDefault.png" alt=" " height=300 width=225> |
- | <b>PhD Biochemical Engineering (? Year). </b><br>I am a student at UCL studying towards a PhD in Biochemical Engineering. Previously, I studied a Masters degree at UCL in Biochemical Engineering and an undergraduate degree in Biomedical Sciences at University of Westminster. I had followed iGEM distantly during my undergraduate degree, and found its concept and deliverables very interesting. I have been in UCL’s iGEM team in previous years and have enjoyed the experience, I therefore decided to participate in the iGEM project this year, to apply and enhance my knowledge in molecular and synthetic biology. <br><br> | + | <b>PhD Biochemical Engineering (? Year). </b><br>I am a student at UCL studying towards a PhD in Biochemical Engineering. Previously, I studied a Masters degree at UCL in Biochemical Engineering and an undergraduate degree in Biomedical Sciences at University of Westminster. I had followed iGEM distantly during my undergraduate degree, and found its concept and deliverables very interesting. I have been in UCL’s iGEM team in previous years and have enjoyed the experience, I therefore decided to participate in the iGEM project this year, to apply and enhance my knowledge in molecular and synthetic biology. <br><br><br><br><br><br><br> |
</p> | </p> | ||
Revision as of 12:12, 25 June 2014